Wellington J, Nur A, Nicholas A, Uwishema O, Chaito H, Awosiku O, et al. Marburg virus outbreak in Ghana: An impending crisis. Ann Med Surg. 2022;81:104377.

Article  Google Scholar 

chronology @ www.cdc.gov [Internet]. Available from: https://www.cdc.gov/vhf/marburg/outbreaks/chronology.html.

Feldmann H, Slenczka W, Klenk HD. Emerging and reemerging of filoviruses. Arch Virol Suppl. 1996;11:77–100.

PubMed  Google Scholar 

Elsheikh R, Makram AM, Selim H, Nguyen D, Le TTT, Tran V-P, et al. Reemergence of Marburgvirus disease: Update on current control and prevention measures and review of the literature. Rev Med Virol [Internet]. 2023;33:e2461. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/rmv.2461.

Nsomo N. Marburg virus disease - Equatorial Guinea and the United Republic of Tanzania. 2023;1–8.

2023-DON472 @ www.who.int [Internet]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON472.

2023-DON471 @ www.who.int [Internet]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON471.

•• Araf Y, Maliha ST, Zhai J, Zheng C. Marburg virus outbreak in 2022: A public health concern. Lancet Microbe. 2022. A description about the need of raising concern among people worldwide to prevent future outbreak and possible pandemic of Marburg virus disease.

2022-DON409 @ www.who.int [Internet]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON409.

beating-marburg-virus-outbreak-ghanas-journey-victory @ reliefweb.int [Internet]. Available from: https://reliefweb.int/report/ghana/beating-marburg-virus-outbreak-ghanas-journey-victory.

• Sah R, Mohanty A, Reda A, Siddiq A, Mohapatra RK, Dhama K. Marburg virus re-emerged in 2022: Recently detected in Ghana, another zoonotic pathogen coming up amid rising cases of Monkeypox and ongoing COVID-19 pandemic- global health concerns and counteracting measures. Vet Q. 2022;42:167–71. The impact of Marburg virus spread on global health amid the COVID-19 and monkeypox is described.

Article  PubMed  PubMed Central  Google Scholar 

Brainard J, Pond K, Hooper L, Edmunds K, Hunter P. Presence and persistence of Ebola or Marburg virus in patients and survivors: A rapid systematic review. PLoS Negl Trop Dis. 2016;10:e0004475.

Article  PubMed  PubMed Central  Google Scholar 

Glaze ER, Roy MJ, Dalrymple LW, Lanning LL. A comparison of the pathogenesis of Marburg virus disease in humans and nonhuman Primates and evaluation of the suitability of these animal models for predicting clinical efficacy under the “Animal Rule.” Comp Med. 2015;65:241–59.

PubMed  PubMed Central  Google Scholar 

Messaoudi I, Amarasinghe GK, Basler CF. Filovirus pathogenesis and immune evasion: Insights from Ebola virus and Marburg virus. Nat Rev Microbiol. 2015;13:663–76.

Article  PubMed  PubMed Central  Google Scholar 

Pigott DM, Golding N, Mylne A, Huang Z, Weiss DJ, Brady OJ, et al. Mapping the zoonotic niche of Marburg virus disease in Africa. Trans R Soc Trop Med Hyg. 2015;109:366–78.

Article  PubMed  PubMed Central  Google Scholar 

Rodhain F. Bats and viruses: Complex relationships. Bull Soc Pathol Exot. 2015;108:272–89.

Article  PubMed  PubMed Central  Google Scholar 

Morens DM, Breman JG, Calisher CH, Doherty PC, Hahn BH, Keusch GT, et al. The origin of COVID-19 and why it matters. Am J Trop Med Hyg. 2020;103:955–9.

Article  PubMed  PubMed Central  Google Scholar 

•• Meltzer E, Schwartz E. Ebola and Marburg virus infections in resource-rich countries: Implications for future outbreaks. Curr Infect Dis Rep [Internet]. 2023;25:181–8. Available from: https://doi.org/10.1007/s11908-023-00810-y. An important review explaining that rigorous infection-control measures may cause delays in the diagnosis and treatment of other important life-threatening infections.

•• Mane Manohar MP, Lee VJ, Chinedum Odunukwe EU, Singh PK, Mpofu BS, Oxley C. Advancements in Marburg (MARV) virus vaccine research with its recent reemergence in Equatorial Guinea and Tanzania: a scoping review. Cureus. 2023;15:e42014. An important scoping review discusses the status of the Marburg virus-associated vaccine development. This review mentions that although various candidates for Marburg virus therapy/vaccine has been proposed, no vaccine or specific therapy have been approved yet.

Ji X, Olinger GG, Aris S, Chen Y, Gewurz H, Spear GT. Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization. J Gen Virol. 2005;86:2535–42.

Article  PubMed  Google Scholar 

Wang J, Qiao L, Hou Z, Luo G. TIM-1 promotes hepatitis C virus cell attachment and infection. J Virol. 2017;91.

Liu N, Tao Y, Brenowitz MD, Girvin ME, Lai JR. Structural and functional studies on the Marburg virus GP2 fusion loop. J Infect Dis. 2015;212(Suppl 2):S146–53.

Article  PubMed  PubMed Central  Google Scholar 

Dolnik O, Becker S. Assembly and transport of filovirus nucleocapsids. PLoS Pathog. 2022;18:e1010616.

Article  PubMed  PubMed Central  Google Scholar 

Madara JJ, Han Z, Ruthel G, Freedman BD, Harty RN. The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. Future Virol. 2015;10:537–46.

Article  PubMed  PubMed Central  Google Scholar 

Edwards MR, Liu G, Mire CE, Sureshchandra S, Luthra P, Yen B, et al. Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins. Cell Rep. 2016;14:1632–40.

Article  PubMed  PubMed Central  Google Scholar 

Shifflett K, Marzi A. Marburg virus pathogenesis – Differences and similarities in humans and animal models. Virol J. 2019;16:165. https://doi.org/10.1186/s12985-019-1272-z.

Article  PubMed  PubMed Central  Google Scholar 

Bixler SL, Goff AJ. The role of cytokines and chemokines in filovirus infection. Viruses. 2015;7:5489–507.

Article  PubMed  PubMed Central  Google Scholar 

Julkunen I, He F, Maljanen S, Vapalahti O, Melen K, Kakkola L. ID: 71: Ebola and Marburg virus proteins effectively interfere with the activation of TLR and RIG-I signaling pathways. Cytokine [Internet]. 2015;76:78. Available from: https://www.sciencedirect.com/science/article/pii/S1043466615003671.

Mehedi M, Groseth A, Feldmann H, Ebihara H. Clinical aspects of Marburg hemorrhagic fever. Future Virol. 2011;6:1091–106.

Article  PubMed  PubMed Central  Google Scholar 

Kajihara M, Marzi A, Nakayama E, Noda T, Kuroda M, Manzoor R, et al. Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein. J Virol. 2012;86:13467–74.

Article  PubMed  PubMed Central  Google Scholar 

King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, et al. The Marburgvirus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding. Cell Host Microbe. 2018;23:101-109.e4.

Article  PubMed  PubMed Central  Google Scholar 

Amatya P, Wagner N, Chen G, Luthra P, Shi L, Borek D, et al. Inhibition of Marburg virus RNA synthesis by a synthetic anti-VP35 antibody. ACS Infect Dis. 2019;5:1385–96.

Article  PubMed  PubMed Central  Google Scholar 

Edwards MR, Basler CF. Current status of small molecule drug development for Ebola virus and other filoviruses. Curr Opin Virol. 2019;35:42–56.

Article  PubMed  PubMed Central  Google Scholar 

Patel DA, Patel AC, Nolan WC, Zhang Y, Holtzman MJ. High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery. PLoS ONE. 2012;7:e36594.

Article  PubMed  PubMed Central  Google Scholar 

Shehzadi K, Saba A, Yu M, Liang J. Structure-based drug design of RdRp inhibitors against SARS-CoV-2. Top Curr Chem. 2023;381:22.

Article  Google Scholar 

Zhang X, Li A, Li T, Shou Z, Li Y, Qiao X, et al. A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo. Biomed Pharmacother. 2023;162:114595.

Article  PubMed  Google Scholar 

• Peng S, Wang H, Wang Z, Wang Q. Progression of antiviral agents targeting viral polymerases. Molecules. 2022;27:7370. A review on antiviral therapies against viruses via targeting viral polymerases.

Article  PubMed  PubMed Central  Google Scholar 

Ahmed S, Mahtarin R, Ahmed SS, Akter S, Islam MS, Mamun AA, et al. Investigating the binding affinity, interaction, and structure-activity-relationship of 76 prescription antiviral drugs targeting RdRp and Mpro of SARS-CoV-2. J Biomol Struct Dyn. 2021;39:6290–305.

Article  PubMed  Google Scholar 

Quesada Muñoz L, Fernández-Fradejas J, Martinez-Barros H, Sánchez Cuervo M, Martín Rufo M, Pintor Recuenco MDR, et al. Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir. Eur J Hosp Pharm Sci Pract. 2023.

Radoshitzky SR, Iversen P, Lu X, Zou J, Kaptein SJF, Stuthman KS, et al. Expanded profiling of remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro. Sci Rep. 2023;13:3131.

Article  PubMed  PubMed Central  Google Scholar 

Grimes SL, Choi YJ, Banerjee A, Small G, Anderson-Daniels J, Gribble J, et al. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance. MBio. 2023;e0106023.

Ye W, Yao M, Dong Y, Ye C, Wang D, Liu H, et al. Remdesivir (GS-5734) impedes enterovirus replication through viral RNA synthesis inhibition. Front Microbiol. 2020;11:1105.

Article  PubMed  PubMed Central  Google Scholar 

Porter DP, Weidner JM, Gomba L, Bannister R, Blair C, Jordan R, et al. Remdesivir (GS-5734) is efficacious in cynomolgus macaques infected with Marburg virus. J Infect Dis. 2020;222:1894–901.

Article  PubMed  Google Scholar 

Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531:381–5.

Article  PubMed  PubMed Central  Google Scholar 

Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, et al. GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci Rep. 2017;7:43395.

Article  PubMed  PubMed Central  Google Scholar 

Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J. The ambiguous base-pairing and high substrate efficiency of T-705 (favipiravir) ribofuranosyl 5′-triphosphate towards influenza A virus polymerase. PLoS One. 2013;8.

Bixler SL, Bocan TM, Wells J, Wetzel KS, Van Tongeren SA, Dong L, et al. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral Res. 2018;151:97–104.

Article  PubMed  Google Scholar 

Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen THT, Rodallec A, et al. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques. PLoS Med. 2018;15:e1002535.

Article  PubMed  PubMed Central  Google Scholar 

Oestereich L, Lüdtke A, Wurr S, Rieger T,